EWTX

Edgewise Therapeutics
$41.60
+$0.76 (+1.86%)Jul 27, 2026
4.7NeutralMoatMint rating

MoatMint rates Edgewise Therapeutics (EWTX) 4.7 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.3 out of 10.

Key metrics

The numbers that frame EWTX today
Market cap
$4.48B
P/E (TTM)
-25.4
EV / FCF
-29.8
ROIC
-35.1%
Div yield
0%
Debt / equity
0.0
52wk Low
$12.30
52wk High
$48.40

EWTX stock rating

How EWTX scores on quality, value, growth, momentum and financial health
4.7out of 10
Neutral overallFair business, expensive priceTop 53% of ~5,000 US stocks
QualityPoor1.3/10
GrowthNeutral5.2/10
MomentumGreat9.6/10
ValueFair3.1/10
Financial HealthGood6.6/10

Growth

Revenue and earnings trend for EWTX
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about EWTX
Is Edgewise Therapeutics a good buy?
Hold. Edgewise Therapeutics has excellent momentum, but poor quality makes the setup mixed. Growth looks mixed. The support signal is useful, but not decisive. We think Edgewise Therapeutics is selling at a high price.
What is the market capitalization of EWTX?
Edgewise Therapeutics's market capitalization is $4.48B.
What is the P/E ratio for EWTX stock?
Edgewise Therapeutics's current P/E ratio is -25.4.
What is the 52-week high for EWTX stock?
The 52-week high for Edgewise Therapeutics is $48.40. The current close of $41.60 is 14% below that high.
What is the 52-week low for EWTX stock?
The 52-week low for Edgewise Therapeutics is $12.30. The current close of $41.60 is 238.2% above that low.
Does EWTX stock pay dividends?
Edgewise Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for EWTX?
Edgewise Therapeutics's Debt / Equity ratio is 0.01.